CompareDigital DiagnosticsvsEyenuk

Digital Diagnostics is an autonomous AI medical device company best known for IDx-DR, an autonomous system that screens for diabetic retinopathy from retinal images. The product is positioned around retinal screening and care routing rather than ophthalmologist replacement, and specialist follow-up remains essential for every positive screen surfaced through the workflow. Buyers should confirm regulatory clearance, camera and imaging hardware compatibility, downstream referral integration, and program reporting before launching diabetic eye screening across primary care sites today.

For primary care diabetic eye screening sites, Digital Diagnostics is worth a serious look thanks to pioneering autonomous diagnostic ai device. The honest trade-off is that regulatory scope is condition-specific. Pricing is sales-led and scoped per buyer rather than posted publicly. Buyers should still verify EHR or workflow fit, scope, and support before committing.

Eyenuk is an AI eye-screening company offering autonomous detection of diabetic retinopathy, diabetic macular edema, and related retinal conditions. The product is positioned around retinal screening and care routing rather than ophthalmologist replacement, and specialist follow-up remains essential for every positive screen surfaced through the workflow. Buyers should confirm regulatory clearance, camera and imaging hardware compatibility, downstream referral integration, and program reporting before launching diabetic eye screening across primary care sites today.

The clearest fit for Eyenuk is diabetic and multi-disease eye screening programs, with the platform leaning into multi-disease retinal screening focus. Limitations are real: workflow placement is clinic-specific. Pricing is sales-led and scoped per buyer rather than posted publicly. Buyers should confirm validation depth, support coverage, and rollout plan before signing.